Anna Hume
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 10%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Health, Medicine and Society 1
-
- Mycobacterium research and diagnosis 1
- Co-authors
- Charles B. Eaton (4 shared papers)Kate L. Lapane (6 shared papers)Martin A. Weinstock (1 shared paper)Patrick N. A. Harris (3 shared papers)Susanna Magee (1 shared paper)Adam G. Stewart (1 shared paper)Adam Irwin (1 shared paper)Anna Maria Peri (1 shared paper)
- Journals
- The Journal of the American Board of Family Medicine (2 papers)BMJ Quality & Safety (1 paper)Clinical Infectious Diseases (1 paper)Preventive Medicine (1 paper)Emerging infectious diseases (1 paper)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Anna Hume
18 papers receiving 375 citations
Peers
Comparison fields: 5 of 81
- Molecular Medicine 61
- Clinical Biochemistry 54
- Applied Microbiology and Biotechnology 14
- Family Practice 10
- Geriatrics and Gerontology 17
Countries citing papers authored by Anna Hume
This map shows the geographic impact of Anna Hume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hume more than expected).
Fields of papers citing papers by Anna Hume
This network shows the impact of papers produced by Anna Hume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hume. The network helps show where Anna Hume may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Hume, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 93 | |
| 2 | 2022 | 55 | |
| 3 | 2021 | 46 | |
| 4 | Prevalence of hypertension, dyslipidemia, and dyslipidemic hypertension. | 1994 | 32 |
| 5 | Family history and premature coronary heart disease. | 1997 | 29 |
| 6 | 2019 | 27 | |
| 7 | 2007 | 26 | |
| 8 | 2017 | 25 | |
| 9 | 2011 | 19 | |
| 10 | 2019 | 9 | |
| 11 | 1995 | 8 | |
| 12 | 1998 | 6 | |
| 13 | 2019 | 4 | |
| 14 | 2020 | 3 | |
| 15 | Rewards and advancements for clinical pharmacy practitioners | 1995 | 2 |
| 16 | 2024 | 1 | |
| 17 | 2018 | 1 | |
| 18 | The individual patient profile. | 1984 | 1 |
| 19 | Oral contraceptives in the immediate postpartum period. | 1991 | 1 |
About Anna Hume
Anna Hume is a scholar working on General Health Professions, Epidemiology, Clinical Biochemistry, Public Health, Environmental and Occupational Health and Molecular Medicine, having authored 19 papers that have together received 388 indexed citations. Recurring topics across this work include Reproductive Health and Contraception (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Antibiotic Resistance in Bacteria (2 papers), Parasites and Host Interactions (1 paper), Plant Pathogenic Bacteria Studies (1 paper), Hermeneutics and Narrative Identity (1 paper), Health, Medicine and Society (1 paper) and Mycobacterium research and diagnosis (1 paper). The work is most often cited by research in Molecular Medicine (61 citations), Clinical Biochemistry (54 citations), Applied Microbiology and Biotechnology (14 citations), Family Practice (10 citations) and Geriatrics and Gerontology (17 citations). Anna Hume has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Charles B. Eaton, Kate L. Lapane, Martin A. Weinstock, Patrick N. A. Harris, Susanna Magee, Adam G. Stewart, Adam Irwin, Anna Maria Peri, Amy V. Jennison and Haakon Bergh. Their work appears in journals such as The Journal of the American Board of Family Medicine, BMJ Quality & Safety, Clinical Infectious Diseases, Preventive Medicine and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.